A systematic, updated review of Xuezhikang, a domestically developed lipid-lowering drug, in the application of cardiovascular diseases
Article in Acta Pharmaceutica Sinica B (May 2024)
The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.
Article in Acta Pharmaceutica Sinica B (May 2024)
Article in Journal of Integrative Medicine (February 2024)
Book chapter (January 2024)